NCT07123350Active, not recruiting
Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
Evolving Biologic Administration: Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
The goal of this retrospective study is to learn about dosing patterns in patients starting subcutaneous vedolizumab administration and patient outcomes after starting subcutaneous administration. Patients with IBD who are starting subcutaneous vedolizumab administration between September 1, 2023, and March 31, 2025, as part of normal patient care, will be retrospectively reviewed and analyzed.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 7 Aug 2025
- Start date
- 16 Oct 2025
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- Vanderbilt University Medical Center
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT07123350
What you commit to
- Study type: Observational
- Planned participants: 120
- From 16 Oct 2025 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients lost to follow-up or change in provider or medication before SC formulation started
Other
- Patients prescribed SC vedolizumab from a non-VUMC provider
Who the study is looking for
- Patients with Crohn's Disease or Ulcerative Colitis referred to start SC vedolizumab from a VUMC IBD provider and receive at least 1 dose of subcutaneous vedolizumab
- Age 18 years old or older
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vanderbilt University Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.